硫酸化透明质酸的研究概况
A survey of researches on sulphated hyaluronic acid
摘要
目的硫酸化透明质酸具有多种药理作用,如抗凝血、抑制肿瘤坏死因子及对细胞活性的调节作用等,在医药领域具有良好的应用前景。此文介绍了硫酸化透明质酸的合成、性质、药理作用及在医药方面的应用。
出处
《中国生化药物杂志》
CAS
CSCD
北大核心
2011年第6期496-498,共3页
Chinese Journal of Biochemical Pharmaceutics
参考文献25
-
1金艳,凌沛学,张天民.透明质酸衍生物研究进展[J].中国生化药物杂志,2008,29(6):427-429. 被引量:16
-
2Ofosu F A, Modi G J, Blajchman M A, et al. Increased sulphation improves the anticoagulant activities of heparan sulphate and der- matan sulphate[ J]. Biochemistry, 1987,248 ( 3 ) :889-896.
-
3Balazs E A, Hogberg B, Laurent T C. The biological activity of hy- aluronic sulfuric acid [ J ]. Acta Phys Scand, 1951,23 ( 2-3 ) : 168- 178.
-
4Magnani A, Albanese A, Lamponi S, et al. Blood-interaction per- formance of differently sulphated hyaluronic acid[ J ]. Thromb Res, 1996,81 ( 3 ) :383-395.
-
5Satoh T, Hayakawa H, Nagahata M, et al. The basic research on physiological property of functionalized hyaluronan (Ⅱ ) : effect of sulfated hyaluronan on histamine release from the mast cell[ J]. Fi- ber,2004,60 ( 5 ) : 137-143.
-
6Yamada T, Sawada R,Tsuchiya T. The effect of sulfated hyaluronan on the morphological transformation and activity of cultured human astrocytes [ J ]. Biomaterials,2008,29 : 3503-3513.
-
7Renier D, Callegaro L. N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation:US,0037874 AI[ P]. 2002-05-28.
-
8Barbucci R, Benvenuti M, Casolaro M, et al. Sulfated hyaluronic acid as heparin-like material:physicochemical and biological char- acterization[ J]. J Mater Sci-Mater M, 1994,5 ( 11 ) :830-833.
-
9Abatangelo G,Barbucci R, Brun P, et al. Biocompatibility and en- zymatic degradation studies on sulphated hyaluronic acid deriva- tives [ J ]. Biomaterials, 1997,18 ( 21 ) : 1411-1415.
-
10Satoh T, Nishiyama K, Nagahata M. et al. The research on physio- logical property of functionalized hyaluronan: interaction between sulfated hyaluronan and plasma proteins [ J ]. Polym Adv Technol, 2004,15 (12) :720-725.
二级参考文献21
-
1张伟,闫翠娥.透明质酸及其衍生物药物载体[J].化学进展,2006,18(12):1684-1690. 被引量:22
-
2霍美蓉,周建平,魏彦,吕霖.紫杉醇阴离子壳聚糖胶束的制备及其小鼠体内组织分布研究[J].中国药学杂志,2006,41(24):1876-1880. 被引量:5
-
3陈景华,陈静涛,徐政,顾其胜.聚乙二醇制备的透明质酸衍生物的生物降解性[J].中国生化药物杂志,2007,28(2):98-101. 被引量:6
-
4Meyer K, Palmer J W. The polysaccharide of the vitreous humor[ J]. J Biol Chem, 1934,107:629-634.
-
5Lapcik L Jr, Lapcik L, De Smedt S, et al. Hyaluronan: preparation, structure, properties, and applications [ J ]. Chem Rev, 1998, 98 (8) : 2663-2684.
-
6Coradini D, Pellizzaro C, Miglierini G, et al. Hyaluronic acid as drug delivery for sodium butyrate : improvement of the anti-proliferative activity on a breast-cancer cell line[J]. Int J Cancer, 1999,81 (3) :411- 416.
-
7Leonelli F, La Bella A, Migneco L M, et al. Design, synthesis and applications of hyaluronic acid-paclitaxel bioconjugates [ J ]. Molecules, 2008, 13(2) :360-378.
-
8Rosato A, Banzato A, De Luca G, et al. HYTAD1-p20:a new paclitaxelhyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer[J] . Urol Oncol,2006,24(3) :207-215.
-
9Motokawa K, Hahn S K, Nakamura T, et al. Selectively crosslinked hyaluronic acid hydrogels for sustained release formulation of erythropoietin [ J ]. J Biomed Master Res A, 2006,78 (3) : 459-465.
-
10Kuo J W, Swann D A, Prestwich G D. Chemical modification of hyaluronic acid by carbodiimides [ J ]. Bioconjug Chem, 1991,2 ( 4 ) : 232-241.
共引文献15
-
1生举正,凌沛学,王凤山.透明质酸生物合成的研究进展[J].中国生化药物杂志,2009,30(2):135-138. 被引量:9
-
2王超,张明春.透明质酸的制备及作为药用材料方面的应用进展[J].中国医药生物技术,2009,4(6):452-454. 被引量:7
-
3陈祥娥,凌沛学.透明质酸皮肤填充剂的研究进展[J].中国生化药物杂志,2011,32(3):248-251. 被引量:5
-
4冯海,黄鑫,苏李,张惠成,胡勇平.交联透明质酸体外降解和细胞毒性研究[J].浙江工业大学学报,2011,39(6):630-634. 被引量:7
-
5徐新,陆明秋,叶玟希,董华平,施丹萍.己二酸二酰肼交联透明质酸薄膜的制备及性能研究[J].广东化工,2012,39(2):47-48. 被引量:7
-
6徐新,施丹萍,叶玟希,董华平.交联透明质酸衍生物的制备进展[J].广东化工,2012,39(5):99-100. 被引量:5
-
7董海涛,杨占君,董乐乐.骨关节炎的药物治疗进展[J].中国骨与关节杂志,2012,1(3):284-288. 被引量:3
-
8朱向情,董会,黄明华,陈庆华,潘兴华,庞荣清.透明质酸钠/魔芋葡甘聚糖软骨支架材料的研究[J].昆明理工大学学报(自然科学版),2012,37(3):25-30. 被引量:1
-
9王铭章.多糖/石墨烯生物材料的研究应用进展[J].药物生物技术,2013,20(3):276-279. 被引量:1
-
10张堃,简军,张政朴.透明质酸的结构、性能、改性和应用研究进展[J].高分子通报,2015(9):217-226. 被引量:35
-
1FDA批准首个关节炎治疗药物IL-6抑制剂[J].临床合理用药杂志,2010,3(4):23-23.
-
2常怡勇.阿司匹林“立新功”[J].大众健康,2012(3):54-54.
-
3薛静波,刘希英,张鸿芬.海带多糖对小鼠腹腔巨噬细胞的激活作用[J].中国海洋药物,1999,18(3):23-25. 被引量:33
-
4俞鸣,郝继辉,史玉荣,李强,郝希山.蛋白酶体抑制剂和肿瘤相关坏死因子凋亡诱导配体协同诱导肝癌细胞凋亡的机制[J].中华实验外科杂志,2006,23(12):1557-1557. 被引量:1
-
5吴堂明,张俊平,胡振林,钱定华.蛋白激酶C抑制剂H-7抑制肿瘤坏死因子对骨细胞的作用(英文)[J].中国药理学报,1995,16(6):509-511.
-
6吴兴临,金群华,陈志容,张亮.依那西普抑制肿瘤坏死因子研究进展[J].国际骨科学杂志,2006,27(4):194-197. 被引量:4
-
7黄敏聪,潘伟,卢觅佳,张马娟,夏丽娟,宣尧仙.脂多糖对BRL大鼠肝细胞的损伤研究[J].浙江实用医学,2015,20(2):90-92. 被引量:1
-
8李付彬,李杰峰,徐向峰,金艳南,杨贺军,李鹏.来氟米特联合肿瘤坏死因子拮抗剂治疗早期类风湿关节炎的疗效观察[J].风湿病与关节炎,2012,1(2):49-50. 被引量:3
-
9姚中强,栗占国.依那西普在类风湿关节炎的临床应用及进展[J].中国新药杂志,2006,15(11):928-931. 被引量:2
-
10王新波,尹路,黎介寿.鱼油对大鼠腹腔感染早期肝脏肿瘤坏死因子信使核糖核酸表达的影响[J].肠外与肠内营养,1996,3(2):107-107.